Cancer Nanomedicine

• Muut tekijät: Hoskins, Clare (Toimittaja)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
• Aiheet: Technology: general issues; antibody drug conjugate (ADC); PD-L1; tumor spheroid disruption; immune modulation; doxorubicin; graphene oxide; adsorption; cathepsin D; cathepsin L; anti-metastatic enzyme cancer therapy; nanoparticles; targeted delivery system; siRNA; osteopontin; mammary carcinoma; mesenchymal stem cells (MSCs); TAT peptide; PLGA; paclitaxel; nano-engineered MSCs; orthotopic lung tumor model; intracranial glioma; immunotherapy; CPMV; viral nanoparticles; in situ vaccine; albumin nanoparticles; microbubble; ultrasound; theranostics; hepatocellular carcinoma; VX2 tumor; intra-arterial chemotherapy; lung cancer; nanomedicine; clinical status; cancer therapy; breast cancer; cell signaling; active targeting; passive targeting; EPR effect; oncogenes; nanoparticle; drug delivery; ligand; tumor targeting; biodistribution; Mesoporous silica nanoparticle; drug delivery system; target treatment; lanthanide metal; hyaluronic acid; hyaluronidase; drug combination; everolimus; dual-targeting; magnetic nanoparticles; monoclonal antibodies; nanostructured lipid carrier; platelet membrane; biomimicry; plasmonic photothermal therapy; gold nanorods; surgery; bleeding; dogs; cats; stimuli-responsive; DOX; SN38; CSCs; single-walled carbon nanotubes; chirality separation; NASH; drug-gene delivery; near IR hyperspectral imaging; plasmonics; copper; VEGF; glioblastoma; differentiated neuroblastoma; peptidomimetics; real-time quantitative polymerase chain reaction (qPCR); actin; combinatorial therapy; anticancer and antibacterial activity; temoporfin; drug-in-cyclodextrin-in-liposome; hybrid nanoparticles; multicellular tumor spheroids; cyclodextrins; photodynamic therapy article; yet reasonably common within the subject discipline; antitumor strategy; biomimetic core-shell nanoparticles; NK cell-derived exosomes; folate receptor; albumin nanoparticle; microfluidic; cabazitaxel; polydopamine nanoparticles; size; cytotoxicity; iron affinity; FA-DABA-SMA; self-assembly; oncogenic proteins; intracellular disruption; folic receptor alpha; pancreatic cancer; parvifloron D; albumin; erlotinib; photodynamic therapy; lipid nanoparticles; tumor vectorization; verteporfin; ovarian carcinomatosis; spheroids; integrin; RGD peptide; cancer diagnosis; radiotherapy; hyperthermia therapy; biomimetic; nanocarrier; membrane-wrapped; cancer; targeted delivery; photothermal therapy; imaging; cancer nanomedicine; tumor microenvironment; nano-bio interactions; clinical translation; magnetic nanowires; magnetic hyperthermia; magnetic actuation; magnetic drug targeting; titanate nanotubes; gold nanoparticles; vectorization; colloidal stability; docetaxel; prostate cancer; mangiferin; anti-topoisomerase activity; extracellular vesicles; exosomes; chemico-physical functionalization; loading; translational medicine; nanotechnology: bioengineering; anacardic acid; mitoxantrone; targeted drug delivery; liposomes; melanoma; apoptosis; ascorbic acid; angiogenesis; epithelial-to-mesenchymal transition; hypoxia; immunosuppression; metabolism; nanotherapeutics; tumour microenvironment; DNA origami; liposome; remote loading; acute toxicity; organoids; magnetic silica-coated iron oxide nanochains; photothermal treatment; hyperthermia; collagen; cellular microenvironment; lymphadenectomy; magnetometer; sentinel lymph node dissection; SPION; superparamagnetic iron oxide nanoparticles; Vδ2 T cells; zoledronic acid; polymeric nanoconstruct; anti-tumor immunity; colorectal carcinoma; β-cyclodextrin nanosponges; BALB-neuT mice; brain tumours; glioma; blood brain barrier; polymeric nanoparticles; PEGylation; dioleoylphosphatidylethanolamine; poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer; folate; oxidation-sensitive release; cellular interaction; in vitro anti-cancer activity; triple negative breast cancer; organotin; mesoporous silica nanoparticles; MDA-MB-231; theranostic nanomaterials; nanobiotechnology; molecular imaging; nanosystems; nanomicelles; ovarian cancer; tumour targeting; chemotherapeutics; riboflavin; vitamin B2; nanomedicines; secondary structure; mixed micelle; pH responsive; targeted therapy; anti-cancer; shear stress; flow; in vitro; therapeutics; diagnostics; Immunotherapy
• Linkit: DOAB: download the publication; DOAB: description of the publication

Yhteenveto

This special issue brings together cutting edge research and insightful commentary on the currentl state of the Cancer Nanomedicine field.

Ulkoasu

1 electronic resource (510 p.)

ISBN

books978-3-03943-059-8
9783039430581
9783039430598

Pääsy

Open Access